Dianthus Therapeutics Inc (DNTH) Directors and Executive Officers - CSIMarket
CSIMarket
 
Dianthus Therapeutics Inc   (NASDAQ: DNTH)

Dianthus Therapeutics Inc

Officers & Directors


Marino Garcia
President, Chief Executive Officer and Director - (Principal Executive Officer)

Lei Meng
Director

Tomas Kiselak
Director

Ryan Savitz
Chief Financial Officer and Chief Business Officer - (Principal Financial Officer)

Paula Soteropoulos
Director

Anne McGeorge
Director

Jonathan Violin, Ph.D.
Director

Edward Carr
Chief Accounting Officer - (Principal Accounting Officer)

Alison F. Lawton
Director

Leon O. Moulder, Jr.
Director and Chair of the Board ,

Dianthus Therapeutics Inc currently has 92 employees.






DNTH Management Effectiveness DNTH Revenue per Employee DNTH Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.